Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1998 Oct 6;159(7):801–802.

Unconventional therapies for cancer: A refuge from the rules of evidence?

I F Tannock, D G Warr
PMCID: PMC1232739  PMID: 9805028

Full Text

The Full Text of this article is available as a PDF (120.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astin J. A. Why patients use alternative medicine: results of a national study. JAMA. 1998 May 20;279(19):1548–1553. doi: 10.1001/jama.279.19.1548. [DOI] [PubMed] [Google Scholar]
  2. Creagan E. T., Moertel C. G., O'Fallon J. R., Schutt A. J., O'Connell M. J., Rubin J., Frytak S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 1979 Sep 27;301(13):687–690. doi: 10.1056/NEJM197909273011303. [DOI] [PubMed] [Google Scholar]
  3. Kaegi E. Unconventional therapies for cancer: 2. Green tea. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ. 1998 Apr 21;158(8):1033–1035. [PMC free article] [PubMed] [Google Scholar]
  4. Kaegi E. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ. 1998 May 5;158(9):1157–1159. [PMC free article] [PubMed] [Google Scholar]
  5. Kaegi E. Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ. 1998 Jun 2;158(11):1483–1488. [PMC free article] [PubMed] [Google Scholar]
  6. Kaegi E. Unconventional therapies for cancer: 6. 714-X. Task Force on Alternative Therapeutic of the Canadian Breast Cancer Research Initiative. CMAJ. 1998 Jun 16;158(12):1621–1624. [PMC free article] [PubMed] [Google Scholar]
  7. Loprinzi C. L., Goldberg R. M., Su J. Q., Mailliard J. A., Kuross S. A., Maksymiuk A. W., Kugler J. W., Jett J. R., Ghosh C., Pfeifle D. M. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol. 1994 Jun;12(6):1126–1129. doi: 10.1200/JCO.1994.12.6.1126. [DOI] [PubMed] [Google Scholar]
  8. Loprinzi C. L., Kuross S. A., O'Fallon J. R., Gesme D. H., Jr, Gerstner J. B., Rospond R. M., Cobau C. D., Goldberg R. M. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol. 1994 Jun;12(6):1121–1125. doi: 10.1200/JCO.1994.12.6.1121. [DOI] [PubMed] [Google Scholar]
  9. Moertel C. G., Fleming T. R., Creagan E. T., Rubin J., O'Connell M. J., Ames M. M. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985 Jan 17;312(3):137–141. doi: 10.1056/NEJM198501173120301. [DOI] [PubMed] [Google Scholar]
  10. Moertel C. G., Fleming T. R., Rubin J., Kvols L. K., Sarna G., Koch R., Currie V. E., Young C. W., Jones S. E., Davignon J. P. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med. 1982 Jan 28;306(4):201–206. doi: 10.1056/NEJM198201283060403. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES